Well put. iHub boards and their OTC day-trading nature sometimes make it hard to identify real (biotech) companies from snake oil scams. Let's hope the topics trend more towards real, meaningful developments that, as has been pointed out, are not garnered by penny stock profiteers.
It would appear to me that "the company" is either trying to make itself attractive to a buyer or attempting to consolidate it's business focus to save itself after years of money-pit development.
Both scenarios typical of bio companies at this stage and both reason to place a 'hold and watch' status on the issue.
Unfortunately, the company seems to behave like many P&D issues when it comes to PRs, and penny traders respond accordingly...so I would not be surprised to see a PR soon about EMA application submittal and a corresponding pop. I would admit to being a victim and play the pop for a quick flip...furthering the assertion of the companies nature as bogus. 2 months later when they fluff about the apps "acceptance" I would do it again. 4 months later on the approval news...do it again. The company can be in control of the pps if they want to be, but they seem to like to hype it!
I would also not be the least surprised to see dilutive measures imposed if/when the company enters Phase 3 and seeks additional capital investment.
The newer developments are exciting and encouraging but exasperated longs can have a devastating impact on pps increases.
I wouldn't want to be facing the prospect of doubling-down here!
§PMCB
News 
Market Data 
Discover 
